The Food and Drug Administration, in its first enforcement operation with the government of India, recently stopped about 500 shipments of unapproved prescription drugs and combination medical devices from reaching U.S. consumers, the agency announced today. The shipments, many sent through third-party countries to conceal their origin, included about 50 FDA-regulated products, including cancer and HIV medications and opioid products, FDA said. “Consumers and physicians purchasing medicines cannot be assured the products they are receiving are legitimate, safe or effective if they are obtained from outside of the FDA-regulated pharmaceutical supply chain,” said FDA Commissioner Stephen Hahn, M.D.  

Related News Articles

Headline
Learn how hospital and health system leaders such as Richard Bagley, senior vice president, chief supply chain officer, Penn State Health, are looking beyond…
#HealthCareInnovation Thursday Blog
I remember where I was in March 2020, the moment our system had its first Incident Command System call. My family was watching a play in Indianapolis — about…
Headline
Months into the COVID-19 pandemic, the health care supply chain remains strained due to the high demand for personal protective equipment. In this blog Q&A…
Blog
Months into the COVID-19 pandemic, the health care supply chain remains strained due to the high demand for personal protective equipment (PPE) domestically…
Headline
The AHA, American Medical Association, American Society of Health-System Pharmacists, and United States Pharmacopeia last week convened a virtual summit to…
Headline
The House Energy and Commerce Subcommittee on Health today held a hearing on lowering prescription drugs prices, which focused on the drug supply chain.…